Catalyst Wire Dossier Catalyst Wire Dossier

Olesoxime

TRO19622 · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Olesoxime, covering 2016-07-18 to 2019-08-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy (SMA) [Phase 2]

See pricing